348 related articles for article (PubMed ID: 17554716)
1. Fluoroquinolones should not be the first-line antibiotics to treat community-acquired pneumonia in areas of tuberculosis endemicity.
Singh A
Clin Infect Dis; 2007 Jul; 45(1):133; author reply 134-5. PubMed ID: 17554716
[No Abstract] [Full Text] [Related]
2. Should fluoroquinolones be first-line antibiotics in the treatment of community-acquired pneumonia in areas with high incidence of tuberculosis?
Hsueh PR
J Microbiol Immunol Infect; 2007 Oct; 40(5):386-7. PubMed ID: 17932596
[No Abstract] [Full Text] [Related]
3. Fluoroquinolones for treatment of community-acquired pneumonia and tuberculosis: putting the risk of resistance into perspective.
Low DE
Clin Infect Dis; 2009 May; 48(10):1361-3. PubMed ID: 19348596
[No Abstract] [Full Text] [Related]
4. Monotherapy or combination therapy for hospitalized patients with community-acquired pneumonia: not yet the end of the story?
Laterre PF
Clin Infect Dis; 2008 May; 46(10):1510-2. PubMed ID: 18419483
[No Abstract] [Full Text] [Related]
5. Fluoroquinolones in the management of community-acquired pneumonia.
Albertson TE; Dean NC; El Solh AA; Gotfried MH; Kaplan C; Niederman MS
Int J Clin Pract; 2010 Feb; 64(3):378-88. PubMed ID: 20456176
[TBL] [Abstract][Full Text] [Related]
6. Role of gemifloxacin in community-acquired pneumonia.
Tillotson GS
Expert Rev Anti Infect Ther; 2008 Aug; 6(4):405-18. PubMed ID: 18662107
[TBL] [Abstract][Full Text] [Related]
7. Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis.
Dooley KE; Golub J; Goes FS; Merz WG; Sterling TR
Clin Infect Dis; 2002 Jun; 34(12):1607-12. PubMed ID: 12032896
[TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolones in community-acquired pneumonia when tuberculosis is around: an instructive case.
Grupper M; Potasman I
Am J Med Sci; 2008 Feb; 335(2):141-4. PubMed ID: 18277123
[TBL] [Abstract][Full Text] [Related]
9. Community-acquired pneumonia.
Luh JY; Karnath BM
N Engl J Med; 2003 Apr; 348(14):1408-9; author reply 1408-9. PubMed ID: 12672875
[No Abstract] [Full Text] [Related]
10. [Empiric therapy of community-acquired pneumonia: a transatlantic controversy].
Garin N; Nendaz M
Rev Med Suisse; 2006 Jan; 2(50):289-90, 292-4. PubMed ID: 16503046
[TBL] [Abstract][Full Text] [Related]
11. Optimizing therapy for community-acquired pneumonia with the goal of rapid resolution of illness.
File TM; Tan JS
Clin Infect Dis; 2005 Dec; 41(12):1706-8. PubMed ID: 16288391
[No Abstract] [Full Text] [Related]
12. The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila.
Nakamura S; Yanagihara K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Senjyu H; Saito A; Kohno S
J Infect; 2009 Sep; 59(3):222-4. PubMed ID: 19592113
[No Abstract] [Full Text] [Related]
13. Empirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuberculosis.
Long R; Chong H; Hoeppner V; Shanmuganathan H; Kowalewska-Grochowska K; Shandro C; Manfreda J; Senthilselvan A; Elzainy A; Marrie T
Clin Infect Dis; 2009 May; 48(10):1354-60. PubMed ID: 19348594
[TBL] [Abstract][Full Text] [Related]
14. Gemifloxacin (factive).
Med Lett Drugs Ther; 2004 Sep; 46(1192):78-9. PubMed ID: 15452464
[No Abstract] [Full Text] [Related]
15. Community-acquired pneumonia and tuberculosis: differential diagnosis and the use of fluoroquinolones.
Grossman RF; Hsueh PR; Gillespie SH; Blasi F
Int J Infect Dis; 2014 Jan; 18():14-21. PubMed ID: 24211230
[TBL] [Abstract][Full Text] [Related]
16. Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate role of fluoroquinolones.
Schriger DL; Hoffman JR; Cooper RJ; Gupta M
J Emerg Med; 2007 Aug; 33(2):197; discussion 197. PubMed ID: 17692777
[No Abstract] [Full Text] [Related]
17. 13--Antibiotic therapy of community-acquired pneumonia (CAP) caused by atypical agents.
Roig J; Casal J; Gispert P; Gea E
Med Mal Infect; 2006; 36(11-12):680-9. PubMed ID: 17095177
[TBL] [Abstract][Full Text] [Related]
18. Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate role of fluoroquinolones.
Moran G
J Emerg Med; 2006 May; 30(4):377-87. PubMed ID: 16740445
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolone use delays tuberculosis treatment despite immediate mycobacteriology study.
Wang JY; Lee CH; Yu MC; Lee MC; Lee LN; Wang JT
Eur Respir J; 2015 Aug; 46(2):567-70. PubMed ID: 25900374
[No Abstract] [Full Text] [Related]
20. Pulmonary tuberculosis presenting as community-acquired pneumonia.
Asnis DS; Cherian S; Sun T; Shrestha S; Santucci T
Clin Infect Dis; 2002 Dec; 35(12):1574-5. PubMed ID: 12471584
[No Abstract] [Full Text] [Related]
[Next] [New Search]
